ATOS
Price
$0.96
Change
-$0.02 (-2.04%)
Updated
Dec 20 closing price
95 days until earnings call
AXON
Price
$631.69
Change
+$16.01 (+2.60%)
Updated
Dec 20 closing price
72 days until earnings call
Ad is loading...

ATOS vs AXON

Header iconATOS vs AXON Comparison
Open Charts ATOS vs AXONBanner chart's image
Atossa Therapeutics
Price$0.96
Change-$0.02 (-2.04%)
Volume$1.09M
CapitalizationN/A
Axon Enterprise
Price$631.69
Change+$16.01 (+2.60%)
Volume$7.03M
CapitalizationN/A
ATOS vs AXON Comparison Chart
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. AXON commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a Hold and AXON is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ATOS: $0.96 vs. AXON: $631.69)
Brand notoriety: ATOS and AXON are both not notable
ATOS represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ATOS: 139% vs. AXON: 706%
Market capitalization -- ATOS: $121.66M vs. AXON: $48.16B
ATOS [@Biotechnology] is valued at $121.66M. AXON’s [@Aerospace & Defense] market capitalization is $48.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $182.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Aerospace & Defense] industry is $14.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 3 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 3 green, 2 red.
According to our system of comparison, AXON is a better buy in the long-term than ATOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 4 TA indicator(s) are bullish while AXON’s TA Score has 3 bullish TA indicator(s).

  • ATOS’s TA Score: 4 bullish, 7 bearish.
  • AXON’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AXON is a better buy in the short-term than ATOS.

Price Growth

ATOS (@Biotechnology) experienced а -13.96% price change this week, while AXON (@Aerospace & Defense) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.59%. For the same industry, the average monthly price growth was +7.06%, and the average quarterly price growth was +24.55%.

Reported Earning Dates

ATOS is expected to report earnings on Mar 27, 2025.

AXON is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+1.59% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($48.2B) has a higher market cap than ATOS($122M). AXON YTD gains are higher at: 144.528 vs. ATOS (9.511). AXON has higher annual earnings (EBITDA): 408M vs. ATOS (-29.46M). AXON has more cash in the bank: 1.16B vs. ATOS (74.8M). ATOS has less debt than AXON: ATOS (0) vs AXON (721M). AXON has higher revenues than ATOS: AXON (1.94B) vs ATOS (0).
ATOSAXONATOS / AXON
Capitalization122M48.2B0%
EBITDA-29.46M408M-7%
Gain YTD9.511144.5287%
P/E RatioN/A164.08-
Revenue01.94B-
Total Cash74.8M1.16B6%
Total Debt0721M-
FUNDAMENTALS RATINGS
ATOS vs AXON: Fundamental Ratings
ATOS
AXON
OUTLOOK RATING
1..100
5194
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
1002
SMR RATING
1..100
9652
PRICE GROWTH RATING
1..100
642
P/E GROWTH RATING
1..100
10030
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATOS's Valuation (28) in the Medical Specialties industry is somewhat better than the same rating for AXON (92) in the Biotechnology industry. This means that ATOS’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (2) in the Biotechnology industry is significantly better than the same rating for ATOS (100) in the Medical Specialties industry. This means that AXON’s stock grew significantly faster than ATOS’s over the last 12 months.

AXON's SMR Rating (52) in the Biotechnology industry is somewhat better than the same rating for ATOS (96) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than ATOS’s over the last 12 months.

AXON's Price Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ATOS (64) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than ATOS’s over the last 12 months.

AXON's P/E Growth Rating (30) in the Biotechnology industry is significantly better than the same rating for ATOS (100) in the Medical Specialties industry. This means that AXON’s stock grew significantly faster than ATOS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATOSAXON
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 5 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
60%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPI0.430.03
+8.20%
SPI Energy Co Ltd
TFSL12.740.16
+1.27%
TFS Financial Corp
KOF79.630.98
+1.25%
Coca-Cola FEMSA SAB DE CV
HCSG11.30-0.14
-1.22%
Healthcare Services Group
TRVG2.26-0.05
-2.16%
trivago NV